Brooks Steriscience

Brooks Steriscience is a specialty pharmaceutical company focused on the development, manufacturing, and marketing of complex sterile injectables. Established as a strategic collaboration between Brooks Laboratories and Steriscience Specialties (a venture promoted by the founders of Strides Pharma), the company operates a dedicated facility for manufacturing carbapenems. Their portfolio includes high-value, critical care antibiotics such as Meropenem, Ertapenem, and Imipenem/Cilastatin. The company provides contract development and manufacturing services (CDMO) to global pharmaceutical partners, leveraging its EU-GMP and USFDA-compliant infrastructure to target regulated markets.